Monique Debruin, MD

Offices

5 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group

Looking this up.

Hospitals listed: Good Samaritan Hospital. That is not proof they admit you there this week.

Plans that list them

14 plans · 2 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Debruin’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

14 of 14 plans

Sort by

Plans whose provider directory lists this clinician

Alignment Health BreathEasy (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Clarity (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Harmony (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)	Alignment Health Plan	Listed	Sep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)	Alignment Health Plan	Listed	Sep 28, 2026
Alignment Health Honor+ Plan (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health My Choice CalCare (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Silicon (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Sutter Advantage +More (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health smartHMO (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health the ONE (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
DualConnect (HMO D-SNP)	Santa Clara Family Health Plan	Listed	Sep 1, 2026

California Medical Board record

Licence A101336 · Current

Licensed to practise in California · since 2007 · expires 2027-05-31 · University of California San Francisco School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend it
Overall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025

See every measure and the patient survey for Good Samaritan Hospital

Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Sort by

Every scored measure at Good Samaritan Hospital

Clostridium Difficile (C.Diff)Infections	0.337	Better	Oct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths	0.75 (0 to 1.67) · 1,340 cases	No different	Jul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths	0.84 (0.54 to 1.14)	No different	Jul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths	143.59 (98.7 to 188.49) · 98 cases	No different	Jul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths	1.7 · 45 cases	None	Jul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths	7.1 · 100 cases	None	Jul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths	12.7 · 270 cases	None	Jul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths	11.3 · 573 cases	None	Jul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths	15.6 · 820 cases	None	Jul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths	8.5 · 482 cases	None	Jul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths	3.3 · 3,711 cases	None	Jul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths	0.12 (0 to 0.3) · 8,866 cases	No different	Jul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths	0.2 (0.01 to 0.38) · 9,051 cases	No different	Jul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths	2.65 (0.74 to 4.56) · 1,929 cases	No different	Jul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths	1.8 (0.21 to 3.39) · 670 cases	No different	Jul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths	2.33 (0.88 to 3.78) · 1,836 cases	No different	Jul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths	6.73 (0 to 13.46) · 669 cases	No different	Jul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths	7.58 (3.96 to 11.19) · 654 cases	No different	Jul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths	1.59 (0.13 to 3.04) · 496 cases	No different	Jul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths	0.27 (0 to 0.87) · 7,373 cases	No different	Jul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths	4.1 · 152 cases	None	Apr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections	1.08	No different	Oct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections	0.542	No different	Oct 2024 – Sep 2025
MRSA BacteremiaInfections	0.484	No different	Oct 2024 – Sep 2025
SSI - Colon SurgeryInfections	1.565	No different	Oct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits	15.8 · 327 cases	None	Jul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits	24.2 · 703 cases	None	Jul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits	61.1 · 289 cases	None	Jul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits	36.3 · 665 cases	None	Jul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits	25.4 · 856 cases	None	Jul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits	19 · 978 cases	None	Jul 2023 – Jun 2025
Rate of readmission after hip/knee replacementUnplanned return visits	6.3 · 144 cases	None	Jul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits	12.3 · 46 cases	None	Jul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits	21.2 · 135 cases	None	Jul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits	13.8 (10.1 to 18.6) · 129 cases	No different	Jan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits	1.2 (0.9 to 1.5) · 531 cases	No different	Jan 2024 – Dec 2024

What patients said (704 patients answered, 24% of those asked)

Sort by

Patient survey stars by topic at Good Samaritan Hospital

Cleanliness	3
Nurse communication	3
Doctor communication	2
Communication about medicines	2
Discharge information	3
Overall hospital rating	2
Quietness	1
Recommend hospital	3

Sort by

Share of patients giving the best answer at Good Samaritan Hospital

Room was "always" clean	66%
Nurses "always" communicated well	75%
Doctors "always" communicated well	71%
Staff "always" explained	54%
Yes, staff "did" give patients this information	83%
Yes, staff "did" give patients information about help after discharge	81%
Doctors "always" explained things so they could understand	66%
Doctors "always" listened carefully	69%
Doctors "always" treated them with courtesy and respect	78%
Patients who gave a rating of "9" or "10" (high)	63%
Staff "always" explained new medications	68%
Nurses "always" explained things so they could understand	69%
Nurses "always" listened carefully	73%
Nurses "always" treated them with courtesy and respect	82%
"Always" quiet at night	38%
"YES", patients would definitely recommend the hospital	67%
Staff "always" explained possible side effects	40%
Yes, staff "did" give patients information about possible symptoms	86%

Original Medicare doctor bills

$43,167

Medicare paid this office $43,167 for 128 people. Most of that is long return visits and Botox.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Sort by

Largest Original Medicare bills

Long return visit (40+ min)	37	$6,184	$159
Return visit (30+ min)	21	$1,968	$94
New patient visit (30+ min)	13	$1,248	$96
Short return visit (20+ min)	16	$1,171	$73
New patient visit (15+ min)	11	$779	$71

Who their Medicare patients are

128 Original Medicare patients in 2024. Average age 73 · Women 77% · Health risk score 0.89. At or below the middle of the specialty; the typical hematology-oncology clinician is at 2.04.

Conditions among them: High blood pressure 53% · Cancer 45% · Diabetes 18% · Coronary heart disease 18% · Chronic kidney disease 16% · Depression 16% · Atrial fibrillation 9%.

The office billed $157,201, Medicare allowed $56,140 and paid $43,167; for 1,871 services of 38 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Sort by

Original Medicare by year

2024	128	1,871	73	0.89	$157,201	$43,167
2023	88	105	72	0.71	$40,470	$12,076
2022	92	118	73	0.91	$41,271	$12,477
2021	79	1,134	72	1.06	$77,751	$30,696
2020	156	16,410	73	1.71	$1,116,951	$369,514
2019	61	1,343	72	1.64	$165,578	$62,410
2018	87	5,784	72	1.57	$334,877	$97,965
2017	63	2,781	74	1.96	$251,960	$70,287
2016	146	11,713	75	2.28	$774,075	$240,440
2015	276	54,263	74	1.69	$2,363,233	$695,574
2014	110	16,053	73	1.72	$917,780	$234,932
2013	95	6,912	72	1.69	$494,210	$124,747

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 5 services

Sort by

Original Medicare services billed in 2023

Long return visit (40+ min)	26	$4,234	$146
New patient visit (60+ min)	11	$2,274	$207
Return visit (30+ min)	18	$2,127	$112
New patient visit (30+ min)	12	$1,156	$96
Short return visit (20+ min)	15	$1,013	$68

2022: 4 services

Sort by

Original Medicare services billed in 2022

Long return visit (40+ min)	31	$4,210	$124
Return visit (30+ min)	16	$2,225	$117
New patient visit (30+ min)	14	$1,434	$102
Short return visit (20+ min)	11	$870	$79

2021: 3 services

Sort by

Original Medicare services billed in 2021

Long return visit (40+ min)	15	$3,317	$175
Return visit (30+ min)	21	$2,521	$110
Telephone medical discussion with physician, 11-20 minutes	20	$1,340	$67

2020: 12 services

Sort by

Original Medicare services billed in 2020

Administration of chemotherapy into vein, 1 hour or less	34	$7,042	$153
Return visit (30+ min)	23	$2,815	$91
Long return visit (40+ min)	14	$2,091	$131
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	19	$2,000	$77
Telephone medical discussion with physician, 11-20 minutes	20	$1,537	$73
Administration of chemotherapy into vein, each additional hour	14	$891	$32
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less	12	$753	$33
Injection of additional new drug or substance into vein	17	$710	$17
Injection of drug or substance under skin or into muscle	17	$358	$14
Injection, dexamethasone sodium phosphate, 1 mg	14	$22	None
Injection, ondansetron hydrochloride, per 1 mg	16	$21	None
Injection, diphenhydramine hcl, up to 50 mg	11	$10	None

2019: 2 services

Sort by

Original Medicare services billed in 2019

Long return visit (40+ min)	23	$4,430	$130
Return visit (30+ min)	27	$2,920	$83

2018: 2 services

Sort by

Original Medicare services billed in 2018

Long return visit (40+ min)	23	$5,169	$123
Return visit (30+ min)	27	$3,622	$93

2017: 3 services

Sort by

Original Medicare services billed in 2017

Long return visit (40+ min)	14	$2,030	$135
Administration of chemotherapy into vein, 1 hour or less	11	$1,791	$138
Return visit (30+ min)	18	$1,754	$76

2016: 10 services

Sort by

Original Medicare services billed in 2016

Administration of chemotherapy into vein, 1 hour or less	32	$6,645	$138
Long return visit (40+ min)	21	$6,423	$128
Return visit (30+ min)	45	$5,858	$78
Injection of additional new drug or substance into vein	24	$1,804	$23
Administration of additional new drug or substance into vein, 1 hour or less	11	$1,343	$64
Administration of chemotherapy into vein, each additional hour	15	$794	$28
Injection of drug or substance under skin or into muscle	23	$710	$25
Injection, dexamethasone sodium phosphate, 1 mg	17	$34	None
Injection, ondansetron hydrochloride, per 1 mg	15	$19	None
Injection, diphenhydramine hcl, up to 50 mg	16	$10	None

2015: 23 services

Sort by

Original Medicare services billed in 2015

Injection, bevacizumab, 10 mg	12	$91,677	None
Administration of chemotherapy into vein, 1 hour or less	91	$28,776	$147
Injection, infliximab, excludes biosimilar, 10 mg	11	$22,298	None
Injection, tbo-filgrastim, 5 micrograms	18	$15,204	None
Long return visit (40+ min)	43	$13,352	$139
Return visit (30+ min)	47	$7,314	$100
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes	22	$6,743	$98
Injection of additional new drug or substance into vein	68	$6,326	$24
Administration of additional new drug or substance into vein, 1 hour or less	38	$4,451	$67
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	29	$4,437	$75
Injection of drug or substance under skin or into muscle	47	$3,488	$26
New patient visit (60+ min)	17	$3,147	$185
Administration of chemotherapy into vein, each additional hour	28	$2,461	$30
Injection, zoledronic acid, 1 mg	14	$2,032	None
New patient visit (45+ min)	12	$1,774	$148
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less	24	$1,440	$32
Injection of drug or substance into vein	14	$1,352	$61
Injection, carboplatin, 50 mg	25	$1,230	None
Injection, paclitaxel, 1 mg	21	$1,228	None
Irrigation of implanted venous access drug delivery device	12	$435	$27
Injection, dexamethasone sodium phosphate, 1 mg	60	$144	None
Injection, ondansetron hydrochloride, per 1 mg	52	$72	None
Injection, diphenhydramine hcl, up to 50 mg	36	$34	None

2014: 12 services

Sort by

Original Medicare services billed in 2014

Administration of chemotherapy into vein, 1 hour or less	49	$11,778	$137
Long return visit (40+ min)	16	$3,867	$133
Injection of additional new drug or substance into vein	44	$3,605	$22
Administration of additional new drug or substance into vein, 1 hour or less	27	$2,895	$63
Administration of chemotherapy into vein, each additional hour	25	$1,833	$28
Administration of additional new drug or substance into vein using push technique	11	$1,121	$62
Injection of drug or substance under skin or into muscle	19	$747	$25
Injection, carboplatin, 50 mg	18	$658	None
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less	13	$631	$30
Injection, dexamethasone sodium phosphate, 1 mg	42	$86	None
Injection, ondansetron hydrochloride, per 1 mg	31	$33	None
Injection, diphenhydramine hcl, up to 50 mg	21	$18	None

2013: 6 services

Sort by

Original Medicare services billed in 2013

Administration of chemotherapy into vein, 1 hour or less	20	$3,825	$147
Long return visit (40+ min)	15	$2,510	$132
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	18	$1,927	$77
Return visit (30+ min)	14	$1,590	$99
Injection of drug or substance under skin or into muscle	13	$668	$26
Injection of additional new drug or substance into vein	11	$566	$23

Drugs they prescribed that Part D paid

$1,172

Pharmacies billed $1,172 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 45) in 2024. Too few prescriptions to compare fairly with other clinicians.

45 generic and 0 brand-name prescriptions · $1,172 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Sort by

Largest Part D drug costs

Raloxifene	20	$724	$36
Tamoxifen Citrate	15	$269	$18

Year by year

Sort by

Part D prescribing by year

2024	45	14	0% (0)	0%	$1,172
2023	23	None	0% (0)	0%	$2,261
2022	38	13	0% (0)	0%	$5,321
2021	39	13	0% (0)	None	$7,605
2020	45	13	0% (0)	24%	$14,409
2019	85	16	0% (0)	31%	$21,573
2018	89	21	0% (0)	None	$16,609
2017	49	18	0% (0)	None	$3,677
2016	176	29	None	None	$182,208
2015	165	33	9% (14)	None	$15,655
2014	29	None	None	None	$1,022
2013	19	None	None	0%	$601

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 1 drug

Sort by

Part D drugs prescribed in 2023

Raloxifene	13	$2,038	$157

2022: 1 drug

Sort by

Part D drugs prescribed in 2022

Raloxifene	29	$4,975	$172

2021: 1 drug

Sort by

Part D drugs prescribed in 2021

Raloxifene	26	$4,126	$159

2020: 1 drug

Sort by

Part D drugs prescribed in 2020

Raloxifene	13	$2,837	$218

2019: 3 drugs

Sort by

Part D drugs prescribed in 2019

Eliquis	24	$16,085	$670
Raloxifene	20	$3,557	$178
Gabapentin	11	$74	$7

2018: 2 drugs

Sort by

Part D drugs prescribed in 2018

Raloxifene	15	$3,569	$238
Gabapentin	11	$56	$5

2016: 4 drugs

Sort by

Part D drugs prescribed in 2016

Exemestane	14	$4,879	$349
Anastrozole	12	$363	$30
Mirtazapine	16	$276	$17
Prochlorperazine Maleate	15	$113	$8

2015: 5 drugs

Sort by

Part D drugs prescribed in 2015

Anagrelide	16	$1,293	$81
Ondansetron	17	$392	$23
Anastrozole	14	$335	$24
Omeprazole	13	$96	$7
Prochlorperazine Maleate	13	$87	$7

Professional record

NPI: 1457532731
Licence: CA A101336California A101336: Current · expires 2027-05-31
Trained: University of California, San Francisco School of Medicine, 2006
Group: Sutter Bay Medical Foundation
Video visits: Lists video visits
Gender: Female

More record details

Sole proprietor: No
Taxonomy: Federal specialty code 207RH0003X (207RH0003X); Internal medicine (207R00000X)
Mailing address: 2350 W El Camino Real, 2nd Floor, Mountain View, CA, 94040
NPI first listed: 2007-11-15
NPI last updated: 2013-08-12

This is when the NPI record was last certified, not a medical board exam.